Inventor · disambiguated record
Travis Young
Also filed as: YOUNG TRAVIS · YOUNG TRAVIS S
15 granted patents·10 pending applications·67 citations·filing 2007–2022
90Inventor score
Files withSCRIPPS RESEARCH INST14YOUNG TRAVIS3CALIFORNIA INST BIOMEDICAL RES2THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES2CALIFORNIA INSTITUTE FOR BIOMEDICAL RES1
Top patents by PatentIndex Score
25 records- 0196US9624276B2Peptidic chimeric antigen receptor T cell switches and uses thereofCALIFORNIA INST BIOMEDICAL RES·Filed 2015·Granted Apr 18, 2017·28 cites·25 claims
- 0291US10391155B2Peptidic chimeric antigen receptor T cell switches and uses thereofSCRIPPS RESEARCH INST·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 0391US8609383B2Production of carrier-peptide conjugates using chemically reactive unnatural amino acidsYOUNG TRAVIS·Filed 2009·Granted Dec 17, 2013·13 cites·6 claims
- 0490US11174306B2Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereofSCRIPPS RESEARCH INST·Filed 2017·Granted Nov 16, 2021·7 cites·17 claims
- 0589US10800828B2Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancerSCRIPPS RESEARCH INST·Filed 2016·Granted Oct 13, 2020·4 cites·16 claims
- 0688US11091546B2Optimized PNE-based chimeric receptor T cell switches and uses thereofSCRIPPS RESEARCH INST·Filed 2016·Granted Aug 17, 2021·6 cites·12 claims
- 0779US8637306B2Production of carrier-peptide conjugates using chemically reactive unnatural amino acidsYOUNG TRAVIS·Filed 2009·Granted Jan 28, 2014·2 cites·23 claims
- 0878US2023355728A1Peptidic chimeric antigen receptor t cell switches and uses thereofSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 0975US9109022B2Production of carrier-peptide conjugates using chemically reactive unnatural amino acidsSCRIPPS RESEARCH INST·Filed 2013·Granted Aug 18, 2015·1 cites·21 claims
- 1073US7897340B2Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic markerUNIV TEXAS·Filed 2007·Granted Mar 1, 2011·1 cites·11 claims
- 1173US2020197497A1Peptidic chimeric antigen receptor t cell switches and uses thereofSCRIPPS RESEARCH INST·Filed 2019·Application pending·0 cites
- 1271US10501546B2Insulin immunoglobulin fusion proteinsTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2016·Granted Dec 10, 2019·1 cites·20 claims
- 1367US12269869B2Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereofSCRIPPS RESEARCH INST·Filed 2021·Granted Apr 8, 2025·0 cites·24 claims
- 1464US11421033B2Insulin immunoglobulin fusion proteinsSCRIPPS RESEARCH INST·Filed 2019·Granted Aug 23, 2022·0 cites·16 claims
- 1562US9732349B2In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastorisSCRIPPS RESEARCH INST·Filed 2014·Granted Aug 15, 2017·0 cites·14 claims
- 1660US8647840B2In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastorisYOUNG TRAVIS·Filed 2008·Granted Feb 11, 2014·0 cites·24 claims
- 1760US2025332258A1Switchable car-t therapies for treating human cancersSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 1859US2025269023A1Novel therapies with engineered effector cellsSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 1952US2015238631A1Chimeric antigen receptor t cell switches and uses thereofKIM CHANHYUK·Filed 2014·Application pending·0 cites
- 2052US2009197339A1In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastorisSCRIPPS RESEARCH INST·Filed 2008·Application pending·0 cites
- 2149US2022152110A1Switchable Chimeric Antigen Receptor-Engineered Human Natural Killer CellsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2248US12252534B2Humanized anti-CD3 antibodies, conjugates and uses thereofSCRIPPS RESEARCH INST·Filed 2017·Granted Mar 18, 2025·0 cites·20 claims
- 2346US2018104354A1Chimeric antigen receptor t cell switches and uses thereofTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2017·Application pending·0 cites
- 2433US2018100026A1Optimized chimeric receptor t cell switches and uses thereofCALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2016·Application pending·0 cites
- 2532US2017210818A1Constant region antibody fusion proteins and compositions thereofCALIFORNIA INST BIOMEDICAL RES·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Travis Young files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →